READY: REAl-world Data from an Italian compassionate use program of avelumab first-line maintenance for locallY advanced or metastatic urothelial carcinoma
In READY, avelumab 1L maintenance showed clinical benefit in patients in Italy with la/mUC without progression following PBC, including across clinical subgroups, further supporting its use as the standard of care in this setting.
Authors
- Lorenzo Antonuzzo (ORCID: https://orcid.org/0000-0003-3349-5604)
- Luigi Cerbone (ORCID: https://orcid.org/0000-0003-0663-244X)
- A. Necchi
- Sebastiano Buti (ORCID: https://orcid.org/0000-0003-0876-0226)
- Fabio Calabrò (ORCID: https://orcid.org/0000-0002-7863-3540)
- Caterina Messina
- Rosa Tambaro (ORCID: https://orcid.org/0000-0002-4218-8131)
- Francesco Carrozza (ORCID: https://orcid.org/0000-0002-5302-9910)
- Filippo Venturini (ORCID: https://orcid.org/0009-0001-5855-9937)
- U. De Giorgi
- Raffaele Colasanto
- Gregorio E. Fazzi (ORCID: https://orcid.org/0000-0001-7068-8435)
- Giuseppe Di Lorenzo (ORCID: https://orcid.org/0000-0001-7414-1568)
- D. Santini
- M. Maruzzo
- Sergio Bracarda (ORCID: https://orcid.org/0000-0002-0703-2959)
- G. Fornarini
- Roberto Iacovelli (ORCID: https://orcid.org/0000-0002-1750-2117)
- Daniela Cullurà
Institutions
- University of Parma (IT)
- University of Salerno (IT)
- Vita-Salute San Raffaele University (IT)
- Agostino Gemelli University Polyclinic (IT)
- Azienda Ospedaliera San Camillo-Forlanini (IT)
- Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IT)
- Azienda Unità Sanitaria Locale Della Romagna (IT)
- Istituto Oncologico Veneto (IT)
- Merck Serono S.A. (Switzerland) (CH)
- Azienda Ospedaliero-Universitaria Careggi (IT)
- Azienda Ospedaliera S.Maria (IT)
- IRCCS Ospedale San Raffaele (IT)
- Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT)
- Azienda di Rilievo Nazionale ed Alta Specializzazione (IT)
- Ospedale Policlinico San Martino (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- Instituto Nazionale Tumori Regina Elena (IT)
- University of Florence (IT)
- European Institute of Oncology (IT)
- Sapienza University of Rome (IT)
- Merck Serono S.p.A. (Italy) (IT)
Publication Details
- Journal
- ESMO Real World Data and Digital Oncology
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1016/j.esmorw.2024.100068
- Citations
- 16
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 9.16